Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | LIG1 | P18858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3129262 | 0.93 | ACHE (0.37) | ACHEPOLB | |
| SCHEMBL2692984 | 0.86 | KDM4E (0.31) | ACHE | |
| SCHEMBL1244972 | 0.81 | ACHE (0.35) | ACHEPOLB | |
| SCHEMBL25973786 | 0.81 | ACHE (0.35) | ACHE | |
| SCHEMBL966903 | 0.80 | ACHE (0.41) | ACHEPOLB | |
| SCHEMBL2458387 | 0.78 | ACHE (0.40) | ACHEPOLB | |
| SCHEMBL7548140 | 0.78 | ACHE (0.40) | ACHEPOLB | |
| SCHEMBL21001390 | 0.75 | ACHE (0.36) | ACHE | |
| SCHEMBL21001214 | 0.75 | ACHE (0.32) | ACHE | |
| SCHEMBL8594481 | 0.75 | ACHE (0.39) | ACHEPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3049455-B1 | NEW CROSSLINKERS FOR COATING COMPOUNDS | BASF SE (DE) | 2020-11-25 | — | — | EP | claimed |
| US-10227504-B2 | Crosslinkers for coating compounds | BASF SE (DE) | 2019-03-12 | — | — | US | claimed |
| US-20170226064-A1 | Synthesis of Triethylenetetramines | PHILERA NEW ZEALAND LIMITED (NZ) | 2017-08-10 | — | — | US | claimed |
| US-20160237310-A1 | NEW CROSSLINKERS FOR COATING COMPOUNDS | BASF SE (DE) | 2016-08-18 | — | — | US | claimed |
| EP-3049455-A1 | NEW CROSSLINKERS FOR COATING COMPOUNDS | BASF SE (DE) | 2016-08-03 | — | — | EP | claimed |
| US-20160102060-A1 | Synthesis of Triethylenetetramines | PROTEMIX CORPORATION LIMITED (NZ) | 2016-04-14 | — | — | US | claimed |
| WO-2015043894-A1 | NEW CROSSLINKERS FOR COATING COMPOUNDS | BASF SE (DE) | 2015-04-02 | — | — | WO | claimed |
| US-20060167281-A1 | 1,2,4- Trioxepanes as precursors for lactones | AKZO NOBEL N.V. (NL) | 2006-07-27 | — | — | US | claimed |
| EP-1646618-A1 | 1,2,4,-TRIOXEPANES AS PRECURSORS FOR LACTONES | Akzo Nobel N.V. (NL) | 2006-04-19 | — | — | EP | claimed |
| WO-2005014569-A1 | 1,2,4,-TRIOXEPANES AS PRECURSORS FOR LACTONES | AKZO NOBEL N.V. (NL) | 2005-02-17 | — | — | WO | claimed |
| JP-61189241-A | — | — | None | — | — | JP | disclosed |
| EP-4615896-A1 | SCRATCH RESISTANT ONE-PACK COATING MATERIAL | BASF Coatings GmbH (DE) | 2025-09-17 | — | — | EP | disclosed |
| US-20240209140-A1 | HYDROXYL-FUNCTIONAL THIOETHER COMPOUNDS AND THEIR USE IN CURABLE COMPOSITIONS | BASF COATINGS GMBH (DE) | 2024-06-27 | — | — | US | disclosed |
| WO-2024100307-A1 | SCRATCH RESISTANT ONE-PACK COATING MATERIAL | BASF COATINGS GMBH (DE) | 2024-05-16 | — | — | WO | disclosed |
| EP-4368648-A1 | ALKOXYSILANE-BASED CROSSLINKING AGENT | BASF Coatings GmbH (DE) | 2024-05-15 | — | — | EP | disclosed |
| US-4454328-A | SWEETENERS | PFIZER INC. (US) | 1984-06-12 | — | — | US | disclosed |
| US-4411925-A | STABLE SWEETENERS | PFIZER INC. (US) | 1983-10-25 | — | — | US | disclosed |
| US-4399163-A | ARTIFICIAL SWEETENERS | PFIZER INC. (US) | 1983-08-16 | — | — | US | disclosed |
| EP-0069811-A1 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1983-01-19 | — | — | EP | disclosed |
| EP-0034876-A2 | Branched amides of L-aspartyl-D-amino acid dipeptides and compositions thereof | PFIZER INC. (US) | 1981-09-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160102060-A1 | Synthesis of Triethylenetetramines | PNMT, TES, TPR | ACHE 1513/4885POLB 1118/4885LIG1 2471/4885 |
| US-20170226064-A1 | Synthesis of Triethylenetetramines | PNMT, TES, TPR | ACHE 1513/4885POLB 1118/4885LIG1 2471/4885 |
| US-20060167281-A1 | 1,2,4- Trioxepanes as precursors for lactones | CYP4X1, LSS, RIOX2 | ACHE 1023/4885POLB 4619/4885LIG1 3380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.